Abstract

The oxidative stress caused by endothelial injury is involved in intimal hyperplasia (IH) in vein grafts. Mesenchymal stem cells (MSCs) can home to injured intima and promote endothelial repair. However, MSC apoptosis is increased accompanied by decreased functional activity under oxidative stress. Thus, we investigate whether tumour necrosis factor‐α (TNF‐α) can promote the survival and activity of MSCs under oxidative stress to reduce IH more effectively, and establish what role the NF‐κB pathway plays in this. In this study, we preconditioned MSCs with TNF‐α (TNF ‐α‐PCMSCs) for 24 hrs and measured the activation of the IKK/NF‐κB pathway. EdU and transwell assays were performed to assess proliferation and migration of TNF ‐α‐PCMSCs. Apoptosis and migration of TNF ‐α‐ PCMSCs were evaluated in conditions of oxidative stress by analysis of the expression of Bcl‐2 and CXCR4 proteins. TNF ‐α‐ PCMSCs were transplanted into a vein graft model, so that cell homing could be tracked, and endothelial apoptosis and IH of vein grafts were measured. The results demonstrated that TNF‐α promotes proliferation and migration of MSCs. Furthermore, survival and migration of TNF ‐α‐ PCMSCs under oxidative stress were both enhanced. A greater number of MSCs migrated to the intima of vein grafts after preconditioning with TNF‐α, and the formation of neointima was significantly reduced. These effects could be partially abolished by IKK XII (NF‐κB inhibitor). All these results indicate that preconditioning with TNF‐α can promote survival and migration of MSCs under oxidative stress via the NF‐κB pathway and thus attenuate IH of vein grafts.

Highlights

  • Autologous vein grafts are commonly used for myocardial revascularization around the world

  • We investigated the effect of the tumour necrosis factor-a (TNF-a) on a variety of activities of Mesenchymal stem cells (MSCs), such as survival, migration and secretion

  • Migration assay was performed with a transwell (CorningInc., Corning, NY, USA) containing a polycarbonate membrane filter (8 lm pore size). 200 ll preconditioned MSCs (1.5 9 105/ml) was seeded in the upper chamber and 600 ll complete medium with SDF-1a (100 ng/ml, Proteintech, IL, USA) was placed into the lower well to induce cell migration

Read more

Summary

Introduction

Autologous vein grafts are commonly used for myocardial revascularization around the world. The primary cause of stenosis of vein grafts is oxidative stress caused by injury of the endothelium [4, 5]. MSCs are mobilized to peripheral blood from the bone marrow and home to injured vascular intima to promote endothelial repair [6, 7]. Because of their many advantages, such as ease of isolation and culture, their directional migration and lack of immune rejection, MSCs are considered to have great therapeutic potential for many diseases [8, 9]. The therapeutic effect of the transplantation of MSCs can be seriously reduced

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call